If ever there was a celebrity in health care, it was Dr. Atul Gawande. He frequented the biggest stages in media and medicine. He gave TED talks, interviews with top journalists, and moderated a discussion on health innovation with President Obama. His books and essays for the New Yorker made him not just a sought-after speaker, but the unofficial leader of medicine’s less-is-more movement.

At least, until six months ago, when he became a CEO. Since drawing tremendous attention when he was dispatched by the leaders of Amazon, JPMorgan Chase, and Berkshire Hathaway to create a venture with the long-term goal of transforming health care, Gawande has virtually disappeared from the public eye. He isn’t giving interviews or releasing information about the direction of the new company.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • I bet the good doctor is still scrubbing, trying to get the stench of those vultures off of himself. They attempted to use his good name and crediblity to market their new data collection products, and misinform the public. In Post Fact America, every media outlet covered this story, in an attempt to make this weoponized data collection, more benign. The “news” won’t be covering his actual response to being used, manipulated, and tricked into becoming a mascot for a slow genocide.

Comments are closed.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy